Cleveland-based University Hospitals is embracing artificial intelligence to make daily huddles more efficient for its nurses and physicians.
Category: ROOT
How Biden's budget aims to sustain Medicare, lower costs
President Joe Biden will release his proposed fiscal year 2024 budget this week — which he says will extend the Medicare trust fund by at least 25 years, while lowering costs for Medicare beneficiaries.
Transcarent to acquire 98point6's virtual care platform, affiliated medical providers in $100M deal
Transcarent, a digital health company backed by major health systems, has agreed to acquire the artificial intelligence-powered virtual care platform of 98point6 in a transaction worth up to $100 million.
Hospitals urge Congress to prevent $8B in Medicaid DSH cuts
Nine national groups representing hospitals and health systems — including the American Hospital Association and the Federation of American Hospitals — have urged Congress to address Medicaid disproportionate share hospital cuts, scheduled to begin in …
Why nearly 500 Minnesota nurses left bedside care positions
Members of the Minnesota Nurses Association have identified chronic understaffing, working conditions and management as the top issues causing them to leave bedside care positions, according to a report released March 6 by the union.
9 RCM companies making exec moves
Here are nine revenue cycle management companies that have announced executive leadership changes in 2023:
Mass General to explore VR therapeutics
Boston-based Massachusetts General Hospital is partnering with virtual reality therapeutics company Rocket VR Health on an 80-patient trial that will study the effect VR has on the quality of life for blood cancer patients.
Optim Health names CFO
Julie Wittwer has been named CFO of Savannah, Ga.-based Optim Health System, which includes two hospitals, two ASCs and more than 20 clinics, according to the Savannah Business Journal.
Physician happiness before, after COVID-19: How 29 specialties stack up
Seventy-five percent of physicians were happy outside of work before the pandemic — that dropped to 58 percent after COVID-19.
FDA expects to rule on full approval for Alzheimer's drug by July
The FDA is set to decide whether to fully approve Leqembi, Eisai and Biogen’s Alzheimer’s treatment by July 6, CNBC reported March 6.
